comparemela.com

Latest Breaking News On - Sgct - Page 17 : comparemela.com

AVROBIO, Inc : AVROBIO to Present New Preclinical Data on Vector Safety at ESGCT Annual Congress

AVROBIO, Inc. (Nasdaq: AVRO), a leading clinical-stage gene therapy company working to free people from a lifetime of genetic disease, today announced that it will present new preclinical data on novel

VectorY Announces Preclinical Data on TDP-43 and Oxidized Phospholipids at American Society of Gene and Cell Therapy (ASGCT) Annual Meeting

Aviadobio Ltd: AviadoBio Presents Preclinical Data at ASGCT 2022 Demonstrating that AVB-101 Represents a Novel and Promising Approach to the Treatment of Frontotemporal Dementia

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.